Cyclacel Pharmaceuticals Inc. (CYCC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cyclacel Pharmaceuticals ...

    NASDAQ: CYCC · Real-Time Price · USD
    6.37
    -0.40 (-5.91%)
    At close: Sep 11, 2025, 3:59 PM

    Cyclacel Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Net Income
    		 -1.32K -81 -3.05M -1.96M -3.26M -2.95M -5.27M -6.03M -5.45M -5.8M -7.42M -5.1M -4.58M -4.11M -5.29M -4.99M -5.13M -3.48M
    Depreciation & Amortization
    		 n/a n/a 1K 1K 2K 2K 8K 7K 8K 8K 8K 7K 8K 9K 7K 10K 17K 9K
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a -641K 31K n/a n/a -16.63M -839K -1.26M 15K n/a n/a n/a n/a
    Stock-Based Compensation
    		 7.00 1.67K 93K 107K 189K 203K 322K 391K 359K 401K 387K 389K 350K 380K 304K 320K 278K 255K
    Change in Working Capital
    		 -4.69M -4.84M 1.6M -1.21M -2K 2.27M 1.04M 1.61M 3.79M -1.44M 1.85M -2.27M 2.3M -3.06M 434K -1.55M 617K -352K
    Accounts Receivables
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Accounts Payables
    		 -5.58M -5.5M 259K -1.15M -1.18M 254K -303K 1.54M -733K -206K 2.81M -407K -898K 1.07M 1.71M 569K 356K 270K
    Other Working Capital
    		 886K 658K 1.34M -67K 1.18M 2.02M 1.35M 75K 4.52M -1.23M -957K -1.86M 3.2M -4.13M -1.28M -2.12M 133K -622K
    Other Non-Cash Items
    		 4.69M 1.59M n/a -5K -16K -16K 627K -46K -14K -26K 16.63M 839K 1.26M -15K n/a n/a n/a n/a
    Net Cash from Operating Activities
    		 -1.06K -3.25M -1.36M -3.07M -3.08M -483K -3.91M -4.04M -1.3M -6.86M -5.17M -6.97M -1.92M -6.78M -4.55M -6.21M -4.21M -3.57M
    Operating Cash Flow
    		 -1.06K -3.25K -1.36M -3.07M -3.08M -483K -3.91M -4.04M -1.3M -6.86M -5.17M -6.97M -1.92M -6.78M -4.55M -6.21M -4.21M -3.57M
    PP&E Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a -6K n/a -7 -3K -4K -2K -9K 62K -78K
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a -6K n/a -7 -3K -4K -2K -9K 62K -78K
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Activities
    		 n/a n/a n/a n/a n/a n/a -4.21M 4.21M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Cash from Investing Activities
    		 n/a n/a n/a n/a n/a n/a -4.21M 4.21M n/a -6K n/a -7 -3K -4K -2K -9K 62K -78K
    Net Debt Issuance
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Net Debt Issuance
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Net Debt Issuance
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Stock Issuance
    		 1.92M 3.65M 1K -1K 6.29M -79K 1.05M n/a n/a n/a 92K 1.58M 1.52M n/a 937K 2.95M n/a 18.05M
    Net Common Stock Issuance
    		 1.92M 3.65M 1K -1K 6.29M -79K 1.05M n/a n/a n/a 92K 1.58M 1.52M n/a -3.63M 2.95M n/a 18.05M
    Common Stock Issuance
    		 1.92M 3.65M 1.61M -1K 6.29M -79K 1.05M n/a n/a n/a 92K 1.58M 1.52M n/a -3.63M 2.95M n/a 18.05M
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Preferred Stock Issuance
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Dividends Paid
    		 -41 n/a n/a n/a n/a n/a -50K -50K -51K -50K -50K -50K -51K -50K -50K -50K -51K -50K
    Common Dividends Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Preferred Dividends Paid
    		 n/a n/a n/a n/a n/a n/a -50K -50K -51K -50K -50K -50K -51K -50K -50K -50K -51K -50K
    Other Financing Activities
    		 -1.92M n/a 1.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Net Cash from Financing Activities
    		 1.88K 3.65M 1.61M -1K 6.29M -79K 999K -50K -51K -50K 42K 1.53M 1.47M -50K 887K 2.9M -51K 18M
    Effect of Forex Changes on Cash
    		 1K -86K -102K 50K -3K -18K 345K -134K 85K 7K -234K 65K -118K -91K 4K -105K 66K 18K
    Net Change in Cash
    		 825.00 313K 155K -3.02M 3.2M -580K -2.57M -4.22M -1.27M -6.91M -5.36M -5.37M -562K -6.92M -3.66M -3.42M -4.14M 14.37M
    Cash at End of Period
    		 4.28K 3.45M 3.14M 2.98M 6M 2.8M 3.38M 5.94M 10.16M 11.44M 18.34M 23.71M 29.08M 29.64M 36.56M 40.22M 43.64M 47.78M
    Cash at Beginning of Period
    		 3.45K 3.14M 2.98M 6M 2.8M 3.38M 5.94M 10.16M 11.44M 18.34M 23.71M 29.08M 29.64M 36.56M 40.22M 43.64M 47.78M 33.41M
    Free Cash Flow
    		 -1.06K -3.25K -1.36M -3.07M -3.08M -483K -3.91M -4.04M -1.3M -6.87M -5.17M -6.97M -1.92M -6.78M -4.55M -6.22M -4.15M -3.64M
    Income Taxes Paid
    		 n/a n/a -2K n/a n/a 2K n/a n/a n/a 2K n/a n/a 2K n/a n/a -38K n/a n/a
    Interest Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K n/a n/a
    Source: Financial Modeling Prep. Financial Sources.
    SEC Filings: 10-K · 10-Q

    Add to Watchlist